Courses

This CME/CE program highlights recent advances in the treatment and management of patients with ischemic stroke and transient ischemic attack (TIA). The expert faculty, led by Dr. Stephan Mayer, will first outline pathophysiology of thrombosis, platelet vessel interactions, and recurrent stroke, including discussion of oral antiplatelet agents. The faculty will also review best practices for secondary prevention of stroke and ...
View Course

This CME/CE program provides a comprehensive overview of the diagnosis, risk stratification, and management strategies of acute deep vein thrombosis (DVT) and pulmonary embolism (PE).  There is an emphasis on care in the outpatient setting, and on new therapeutics that may shorten or even obviate the need for hospitalization. The expert faculty discuss clinical data on current therapeutic options, risk-adjusted ...
View Course

This CE activity is derived from content presented at the 2021 ASHP Midyear Clinical Meeting & Exhibition. In this education, the expert faculty, led by Dr. John Fanikos, will analyze pertinent information for hospital and critical care pharmacists related to managing hypertensive emergencies. Hypertensive emergencies lead to acute or progressive end-organ dysfunction. In these cases, blood pressure must be aggressively ...
View Course

This CME/CE program is derived from content presented at the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC). The expert faculty, led by Fred D. Lublin, MD, will highlight the important emerging role of Bruton's tyrosine kinase (BTK) inhibitors as the first brain penetrant disease modifying therapy that offers opportunities to improve neuroinflammation and neurodegeneration. The faculty ...
View Course

This CME program is derived from content presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Conference. Long-term protection from thrombotic/ischemic complications in patients with chronic coronary disease is an increasingly important topic given the aging of the population and the improved survival rates after an acute coronary syndrome (ACS). There are emerging data that support both dual antiplatelet therapy (DAPT) ...
View Course

This CME/CNE activity will highlight updates in secondary prevention of ischemic stroke and transient ischemic attack. The expert faculty, Dr. Stephan Mayer, will first delve into the pathophysiology and disease burden of early recurrent ischemic neurovascular events. Next, Dr. Mayer will review the importance of antiplatelet therapy with both ASA and P2Y₁₂ inhibitors in acute and early secondary prevention. Following, ...
View Course

This CME program is derived from content presented at the Eastern Pulmonary Conference Annual Meeting. The expert faculty, Dr. Anne E. O’Donnell, will first highlight the pathophysiology, prevalence, and high-risk subgroups of non-tuberculous mycobacterial lung disease (NTM-LD). Following, Dr. O’Donnell will analyze current strategies for determining immunocompetent hosts and detecting radiographic manifestations in NTM-LD. The clinical implications of recent trial ...
View Course

This CME/CE program is derived from content presented as part of a larger rheumatology state meeting lecture series. The expert faculty, Dr. Dinesh Khanna, will first discuss the history of systemic sclerosis-associated interstitial lung disease, including prevalence, predictors of progressive ILD and screening. Following, recent clinical trial data in the interstitial lung disease treatment landscape will be reviewed, encompassing both ...
View Course

This CME/CE webcast, chaired by Fred D. Lublin, MD, will analyze current best practices for utilizing fumarate-based therapeutics to improve outcomes in patients with multiple sclerosis (MS). The expert faculty will first review the mechanism of action and targets of fumarates in the MS treatment landscape. Following, current trial data of fumarate-based therapeutics in MS will be reviewed and clinical ...
View Course